Skip to main content

PALISADE CAPITAL MANAGEMENT, LP

Position in JNJ — Johnson & Johnson

CIK 1009006 FORT LEE, NJ

Position in JNJ

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,922,834
+$203,916 QoQ
Shares Held
23,321
-0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#1,487
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

PALISADE CAPITAL MANAGEMENT, LP holds $44,577,032 across 7 Drug Manufacturers - General names. JNJ ranks #3 (13.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 JNJ
Johnson & Johnson
This page
23,321 $5,922,834

All Filings in JNJ

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,922,834 23,321
2026-03-31 $5,718,918 23,396
2025-12-31 $4,777,647 23,086
2025-09-30 $4,370,349 23,570
2025-06-30 $3,615,287 23,668
2025-03-31 $3,946,660 23,798
2024-12-31 $3,714,564 25,685
2024-09-30 $5,522,680 34,078
2024-06-30 $8,220,476 56,243
2024-03-31 $12,477,710 78,878
2023-12-31 $14,102,211 89,972
2023-09-30 $13,931,837 89,450
2023-06-30 $15,158,321 91,580
2023-03-31 $14,196,915 91,593
2022-12-31 $16,284,656 92,186
2022-09-30 $15,030,263 92,007
2022-06-30 $16,529,376 93,118
2022-03-31 $16,507,379 93,141
2021-12-31 $15,890,863 92,891
2021-09-30 $14,925,022 92,415
2021-06-30 $15,320,655 92,999
2021-03-31 $15,345,688 93,372
2020-12-31 $14,436,467 91,730
2020-09-30 $13,616,267 91,458
2020-06-30 $12,015,005 85,437
2020-03-31 $10,573,405 80,633